Information Provided By: 
Fly News Breaks for October 3, 2018
SYK
Oct 3, 2018 | 07:25 EDT
Stryker has underperformed the broader large-cap MedTech space so far this year with shares up only 15% versus 28% for the group "despite a series of strong quarters" year-to-date, JPMorgan analyst Robbie Marcus tells investors in a research note. The analyst sees a "solid entry point" into the stock ahead of what he thinks should be "strong" Q3 results on October 25. Marcus calls his recent investor meetings with Stryker's CFO Glenn Boehnlein "bullish" and he reiterates an Overweight rating on the shares with a $200 price target.
News For SYK From the Last 2 Days
There are no results for your query SYK
